**Patient Discharge Summary**

**Patient Information:**  
- Name: [Patient Name]  
- Age: [Age]  
- Sex: [Sex]  
- Date of Admission: June 10, 2023  
- Date of Discharge: June 20, 2023  
- Hospital ID: [Hospital ID]

**Admitting Physician:** Dr. [Admitting Physician Name]  
**Consulting Team:** Endocrinology Unit

**Chief Complaint:**  
Patient presented to the emergency department on June 10, 2023, with symptoms of excessive thirst, frequent urination, and significant unintentional weight loss over the past month.

**History of Present Illness:**  
[Patient Name], a [Age]-year-old [sex], was admitted to the endocrinology unit with suspected diabetes mellitus after presenting with symptoms indicative of hyperglycemia. No prior history of diabetes or significant family history was reported.

**Diagnostic Findings:**  
- **Fasting Plasma Glucose (FPG):** 280 mg/dL on June 11, 2023
- **Glycosylated Hemoglobin (HbA1C):** 11.2% on June 11, 2023
- **Oral Glucose Tolerance Test (OGTT):** Conducted on June 12, 2023, with a 2-hour value of 320 mg/dL
- **Random Plasma Glucose:** 290 mg/dL on June 10, 2023
- Additional tests for autoantibodies typical of type 1 diabetes (e.g., GAD65) were positive, confirming the diagnosis of type 1 diabetes mellitus.

**Hospital Course:**  
The patient was initially managed with intravenous hydration and insulin therapy to stabilize blood glucose levels. Education on diabetes management, including diet, exercise, self-monitoring of blood glucose, and insulin administration, was provided by a multidisciplinary team including endocrinologists, diabetes educators, and dietitians.

- **Insulin Therapy Initiated:**  
  - Basal insulin: Glargine 20 units at bedtime started on June 12, 2023.
  - Bolus insulin: Lispro initiated at a dose of 1 unit per 15 grams of carbohydrates, with adjustments based on pre-meal blood glucose levels.

- **Diabetes Education:**  
  Comprehensive education on the management of type 1 diabetes, including the importance of blood glucose monitoring, insulin injection techniques, recognition of hypoglycemia and hyperglycemia signs, and dietary management was provided. The patient demonstrated understanding and competency in self-care practices by the end of the stay.

- **Dietary Consultation:**  
  Individualized nutritional counseling was provided, focusing on carbohydrate counting, the importance of fiber, and the distribution of meals to optimize glycemic control.

- **Exercise Recommendations:**  
  Advised at least 150 minutes of moderate-intensity aerobic physical activity per week, with precautions to adjust insulin dosing or carbohydrate intake as needed to prevent hypoglycemia.

**Complications:**  
No significant complications were observed during the hospital stay. The patient's blood glucose levels were brought within target range, and ketonuria resolved with treatment.

**Discharge Medications:**  
- Insulin Glargine 20 units at bedtime
- Insulin Lispro according to carbohydrate counting and pre-meal blood glucose levels
- Multivitamin daily

**Follow-Up:**  
- **Endocrinology:** Follow-up appointment scheduled for July 1, 2023, with Dr. [Endocrinologist Name] for glycemic control assessment and insulin regimen adjustment as necessary.
- **Ophthalmology:** Recommended annual funduscopic examination. First appointment scheduled for August 15, 2023.
- **Podiatry:** Annual foot examination recommended. First visit scheduled for September 10, 2023.
- **Diabetes Education:** Follow-up session with a diabetes educator scheduled for July 15, 2023, to reinforce self-management skills.

**Instructions for Patient:**  
- Continue with prescribed insulin therapy, monitoring blood glucose levels four times a day.
- Follow the dietary plan as advised by the dietician, focusing on balanced meals and carbohydrate counting.
- Engage in recommended physical activity, with precautions to prevent hypoglycemia.
- Attend all scheduled follow-up appointments and maintain regular communication with the diabetes care team.
- Monitor for signs of hypoglycemia and hyperglycemia, and know when to seek immediate medical attention.

**Preventive Measures:**  
- The patient has been advised on the importance of regular screening for diabetic complications, including neuropathy, nephropathy, and retinopathy.
- Vaccinations updated for Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2 as per the current guidelines.

This discharge summary has been discussed in detail with [Patient Name], who expressed understanding of the discharge instructions and follow-up care plan. Copies of this summary have been provided to the patient and the primary care physician.

**Physician's Signature:**  
Dr. [Admitting Physician Name]  
Date: June 20, 2023